Thyroid autoimmunity in bipolar disorder: A systematic review

Journal of Affective Disorders

Volumn 221, Issue , 2017, Pages 97-106

  Barbuti, Margherita ^a,b   Murru, Andrea ^a   Verdolini, Norma ^a,d   Guiso, Giovanni ^a   Vieta, Eduard ^a   Pacchiarotti, Isabella ^a   Perugi, Giulio ^b   Carvalho, André F ^c   Stubbs, Brendon ^k,l   Samalin, Ludovic ^e   Maes, Michael ^f,g,h,i,j  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF PISA   (Italy)

^c Federal University of Ceará   (Brazil)

^d UNIVERSITY OF PERUGIA   (Italy)

^e UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^f CHULALONGKORN UNIVERSITY   (Thailand)

^g DEAKIN UNIVERSITY   (Australia)

^h STATE UNIVERSITY OF LONDRINA   (Brazil)

ⁱ Revitalis   (Netherlands)

^j MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

^k SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^l KING'S COLLEGE LONDON   (United Kingdom)

more..

Author keywords

Bipolar disorder; Lithium treatment; Thyroid autoantibodies; Thyroid autoimmunity

Indexed keywords

LITHIUM; THYROID ANTIBODY; ANTIDEPRESSANT AGENT; AUTOANTIBODY; LITHIUM DERIVATIVE;

AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; BIPOLAR DISORDER; HUMAN; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW (TOPIC); THYROID GLAND; TWIN STUDY; ADULT; BLOOD; ENDOPHENOTYPE; FEMALE; IMMUNOLOGY; MALE; PATHOPHYSIOLOGY; PSYCHOLOGY; RISK FACTOR;

ADULT; ANTIDEPRESSIVE AGENTS; AUTOANTIBODIES; BIPOLAR DISORDER; ENDOPHENOTYPES; FEMALE; HUMANS; LITHIUM COMPOUNDS; MALE; RISK FACTORS; THYROID GLAND; THYROIDITIS, AUTOIMMUNE;

EID: 85020933115     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2017.06.019     Document Type: Review

References (40)

1. Azorin, J.M., Kaladjian, A., Adida, M., Hantouche, E.G., Hameg, A., Lancrenon, S., Akiskal, H.S., Factors associated with rapid cycling in bipolar I manic patients: findings from a French national study. CNS Spectr. 13 (2008), 780–787.
2. Barbero, J.D., Garcia-Pares, G., Llorens, M., Tost, M., Cobo, J., Palao, D., Labad, J., Thyroglobulin antibodies and risk of readmission at one year in subjects with bipolar disorder. Psychiatry Res. 219 (2014), 109–113.
3. Bartalena, L., Pellegrini, L., Meschi, M., Antonangeli, L., Bogazzi, F., Dell'Osso, L., Pinchera, A., Placidi, G.F., Evaluation of thyroid function in patients with rapid-cycling and non-rapid-cycling bipolar disorder. Psychiatry Res. 34 (1990), 13–17.
4. Bauer, M.S., Whybrow, P.C., The effect of changing thyroid function on cyclic affective illness in a human subject. Am. J. Psychiatry 143 (1986), 633–636.
5. Berk, M., Kapczinski, F., Andreazza, A.C., Dean, O.M., Giorlando, F., Maes, M., Yücel, M., Gama, C.S., Dodd, S., Dean, B., Magalhães, P.V., Amminger, P., McGorry, P., Malhi, G.S., Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci. Biobehav. Rev. 35 (2011), 804–817.
6. Bocchetta, A., Loviselli, A., Lithium treatment and thyroid abnormalities. Clin. Pract. Epidemiol. Ment. Heal., 2, 2006, 23.
7. Bocchetta, A., Traccis, F., Mosca, E., Serra, A., Tamburini, G., Loviselli, A., Bipolar disorder and antithyroid antibodies: review and case series. Int. J. Bipolar Disord., 4, 2016, 5.
8. Boelaert, K., Franklyn, J.A., Thyroid hormone in health and disease. J. Endocrinol. 187 (2005), 1–15.
9. Bonnin, C.M., Martinez-Aran, A., Sanchez-Moreno, J., Torrent, C., Franco, C., Pacchiarotti, I., Vieta, E., Bipolar disorder, cognitive functioning and hypothalamic-pituitary-thyroid axis. Actas Esp. Psiquiatr. 38 (2010), 223–228.
10. Carta, M.G., Moro, M.F., Lorefice, L., Trincas, G., Cocco, E., Del Giudice, E., Fenu, G., Colom, F., Marrosu, M.G., The risk of bipolar disorders in multiple sclerosis. J. Affect. Disord. 155 (2014), 255–260.
11. Carvalho, A.F., Kohler, C.A., Fernandes, B.S., Quevedo, J., Miskowiak, K.W., Brunoni, A.R., Machado-Vieira, R., Maes, M., Vieta, E., Berk, M., Bias in emerging biomarkers for bipolar disorder. Psychol. Med. 46 (2016), 2287–2297.
12. Chakrabarti, S., Thyroid functions and bipolar affective disorder. J. Thyroid Res., 2011, 2011, 306367.
13. Cobo, J., Gimenez-Palop, O., Patro, E., Perez, M., Bleda, F., Barbero, J.D., Oliva, J.C., Serrano, R., Berlanga, E., Garcia-Pares, G., Palao, D., Lack of confirmation of thyroid endophenotype in Bipolar Disorder Type I and their first-degree relatives. Psychoneuroendocrinology 51 (2015), 351–364.
14. Cowdry, R.W., Wehr, T.A., Zis, A.P., Goodwin, F.K., Thyroid abnormalities associated with rapid-cycling bipolar illness. Arch. Gen. Psychiatry 40 (1983), 414–420.
15. Cho, J.T., Bone, S., Dunner, D.L., Colt, E., Fieve, R.R., The effect of lithium treatment on thyroid function in patients with primary affective disorder. Am. J. Psychiatry 136 (1979), 115–116.
16. Eaton, W.W., Pedersen, M.G., Nielsen, P.R., Mortensen, P.B., Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disord. 12 (2010), 638–646.
17. Goodwin, F.K., Jamison, K.R., Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression. 2007, Oxford University Press, New York.
18. Grande, I., Berk, M., Birmaher, B., Vieta, E., Bipolar disorder. Lancet 387 (2016), 1561–1572.
19. Haggerty, J.J. Jr., Evans, D.L., Golden, R.N., Pedersen, C.A., Simon, J.S., Nemeroff, C.B., The presence of antithyroid antibodies in patients with affective and nonaffective psychiatric disorders. Biol. Psychiatry 27 (1990), 51–60.
20. Haggerty, J.J. Jr., Silva, S.G., Marquardt, M., Mason, G.A., Chang, H.Y., Evans, D.L., Golden, R.N., Pedersen, C., Prevalence of antithyroid antibodies in mood disorders. Depression Anxiety 5 (1997), 91–96.
21. Hamdani, N., Doukhan, R., Kurtlucan, O., Tamouza, R., Leboyer, M., Immunity, inflammation, and bipolar disorder: diagnostic and therapeutic implications. Curr. Psychiatry Rep., 15, 2013, 387.
22. Hillegers, M.H., Reichart, C.G., Wals, M., Verhulst, F.C., Ormel, J., Nolen, W.A., Drexhage, H.A., Signs of a higher prevalence of autoimmune thyroiditis in female offspring of bipolar parents. Eur. Neuropsychopharmacol. 17 (2007), 394–399.
23. Hornig, M., Amsterdam, J.D., Kamoun, M., Goodman, D.B., Autoantibody disturbances in affective disorders: a function of age and gender?. J. Affect. Disord. 55 (1999), 29–37.
24. Kraszewska, A., Chlopocka-Wozniak, M., Abramowicz, M., Sowinski, J., Rybakowski, J.K., A cross-sectional study of thyroid function in 66 patients with bipolar disorder receiving lithium for 10–44 years. Bipolar Disord. 17 (2015), 375–380.
25. Kupka, R.W., Nolen, W.A., Post, R.M., McElroy, S.L., Altshuler, L.L., Denicoff, K.D., Frye, M.A., Keck, P.E. Jr., Leverich, G.S., Rush, A.J., Suppes, T., Pollio, C., Drexhage, H.A., High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biol. Psychiatry 51 (2002), 305–311.
26. Kupka, R.W., Regeer, E.J., Bipolar mood disorders. Ned. Tijdschr. Geneeskd. 151 (2007), 2256–2260.
27. Leon-Caballero, J., Pacchiarotti, I., Murru, A., Valenti, M., Colom, F., Benach, B., Perez, V., Dalmau, J., Vieta, E., Bipolar disorder and antibodies against the N-methyl-d-aspartate receptor: a gate to the involvement of autoimmunity in the pathophysiology of bipolar illness. Neurosci. Biobehav. Rev. 55 (2015), 403–412.
28. Leyhe, T., Mussig, K., Cognitive and affective dysfunctions in autoimmune thyroiditis. Brain Behav. Immun. 41 (2014), 261–266.
29. Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gotzsche, P.C., Ioannidis, J.P., Clarke, M., Devereaux, P.J., Kleijnen, J., Moher, D., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Br. Med. J., 339, 2009, b2700.
30. Maes, M., Bosmans, E., Calabrese, J., Smith, R., Meltzer, H.Y., Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J. Psychiatr. Res. 29 (1995), 141–152.
31. Nielsen, C.H., Hegedus, L., Leslie, R.G., Autoantibodies in autoimmune thyroid disease promote immune complex formation with self antigens and increase B cell and CD4+ T cell proliferation in response to self antigens. Eur. J. Immunol. 34 (2004), 263–272.
32. Oomen, H.A., Schipperijn, A.J., Drexhage, H.A., The prevalence of affective disorder and in particular of a rapid cycling of bipolar disorder in patients with abnormal thyroid function tests. Clin. Endocrinol. 45 (1996), 215–223.
33. Rege, S., Hodgkinson, S.J., Immune dysregulation and autoimmunity in bipolar disorder: synthesis of the evidence and its clinical application. Aust. N.Z. J. Psychiatry 47 (2013), 1136–1151.
34. Sidhom, O., Laadhar, L., Zitouni, M., Ben Alaya, N., Rafrafi, R., Kallel-Sellami, M., Lahmar, H., El Hechmi, Z., Makni, S., Spectrum of autoantibodies in Tunisian psychiatric inpatients. Immunol. Investig. 41 (2012), 538–549.
35. Silva, L.M., Chavez, J., Canalli, M.H., Zanetti, C.R., Determination of IgG subclasses and avidity of antithyroid peroxidase antibodies in patients with subclinical hypothyroidism - a comparison with patients with overt hypothyroidism. Horm. Res. 59 (2003), 118–124.
36. Siwek, M., Sowa-Kucma, M., Styczen, K., Misztak, P., Nowak, R.J., Szewczyk, B., Dudek, D., Rybakowski, J.K., Nowak, G., Maes, M., Associations of serum cytokine receptor levels with melancholia, staging of illness, depressive and manic phases, and severity of depression in bipolar disorder. Mol. Neurobiol., 2016, 2016 (Epub ahead of print).
37. Vonk, R., van der Schot, A.C., Kahn, R.S., Nolen, W.A., Drexhage, H.A., Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder?. Biol. Psychiatry 62 (2007), 135–140.
38. Wehr, T.A., Goodwin, F.K., Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch. Gen. Psychiatry 36 (1979), 555–559.
39. Wells, G.A., Shea, B., O'Connell, D., Peterson, J., Welch, V., Losos, M., Tugwell, P., The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. 2014, University of Ottawa, Ottawa 〈http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp〉.
40. Whybrow, P.C., Prange, A.J. Jr., Treadway, C.R., Mental changes accompanying thyroid gland dysfunction. A reappraisal using objective psychological measurement. Arch. Gen. Psychiatry 20 (1969), 48–63.